| Term 
 | Definition 
 
        | 1. Platelet Inhibitor 
 2. Anti- Inflammatory
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | TPA (Mechanism of action) |  | Definition 
 
        | 1. Binds to Fibrin-bound plasminogen at the clot site 2. converts plasminogen to plasmin
 3. plasmin digest the fibrin strands at the clot site,
 4. restores perfusion
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | total dose of 100 mg 1. 10 mg IV bolus in 2 minutes
 2. 50 mg over 1 hour
 3. 20 mg over 2nd hour
 4. 20 mg over 3rd hour
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1. 20 mg with 20 mL diluent vial 2. 50 mg with 20 mL diluent vial
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1 mg iv push, repeat 3-5 mins, no max dose, 20 cc flush after dose. |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | potent vasoconstictor when given in high doses |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 40 unit one time dose IV/IO (in first or second dose of epi) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1-1.5 mg/kg to a max of 3mg/kg |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | parasympatholytic: inhibits acetylcholine at receptor sites increases HR in life threatening bradyarrhythmias
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 0.5 mg if alive 1.0 mg if dead
 |  | 
        |  | 
        
        | Term 
 
        | atropine (interaction problems) |  | Definition 
 
        | 1. digoxin 2. cholinergics
 3. physostigmine
 4. effects enhanced
 - antihistamines
 - procainamide
 - quindine
 - antopsychotics
 - benzodiazpines
 - antidepressants
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | reduces striated muscle contractions |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1-2 g (2-4 mL of a 50% solution) diluted in 10 mL of D5W IV/IO over 5-20 mins |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Slows conduction time throught the av nodeSlows HR |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | • 6 mg over 1-3 seconds - followed by 20mL flush
 - if no response after 1-2mins
 - 12 mg over 1-3 minutes
 - if no response, repeat 12mg
 • total maximum dose 30 mg
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Blocks sodium channels Blocks myocardial potassum channels |  | 
        |  | 
        
        | Term 
 
        | Amiodarone (dose: adult) • Vfib/ pulseless, Vtach unresponsive to CPR, Defib, and vasopressors
 |  | Definition 
 
        | • 300 mg IV/IO push • repeat dose 3-5 mins later:
 150 mg IV/IO
 |  | 
        |  | 
        
        | Term 
 
        | Amiodarone (dose: adult) • recurrent life threatening Vent. Arrhythmias.
 |  | Definition 
 
        | • Maximum cumulative dose: 2.2g/ 24 hrs
 • Rapid infusion:
 150 mg IV/IO over 10 mins.
 (15 mg/min), repeat every 10 mins as needed.
 • Slow infusion:
 360 mg IV/IO over 6 hrs
 (1mg/min)
 • maintenance dose:
 540 mg IV/IO over 18 hrs
 (0.5mg/min)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Positive Inotropic properties |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Calcium Chloride (Dose: adult)
 |  | Definition 
 
        | • 500 mg to 1000mg • solution: 5-10 ml in 10%
 - for hyperkalemia and calcium channel blocker over dose.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Sympathomimetic inotropic agent  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Increases myocardial contractilitiy and stroke volume  |  | 
        |  | 
        
        | Term 
 
        | Dobutamine (dose: adults/ peds) |  | Definition 
 
        | •Iv infusion at 2- 20 ug/kg/min |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
SympathomimeticInotropic agent  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Increases systemic vascular resistence dilates renal and splanchnic vasculatureIncreases myocardial contractility and stroke volume |  | 
        |  | 
        
        | Term 
 
        | Dopamine (dose: adult/ped) |  | Definition 
 
        | • 2-20 ug/kg/min titrated to effect |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
5-HT3 receptor antagoinst  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Blocks action of serotonin (causes n/v) |  | 
        |  | 
        
        | Term 
 
        | Ondansetron Hydrochloride (Zofran)
 Dose: adult/ Peds
 |  | Definition 
 
        | • 4mg IV or IM (repeat every ten mins) • 0.1 mg/kg IV or IM
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Calcium Channel BlockerClass IV antiarrhythmicProlongs AV nodal refractory Dilates Coronary artiers and arterioles |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
2.5 - 5.0 mg IV blous over 2 minutesRepeat dose: 5-10 mg may be given every 15-30 minutesmaximum dose: 20 mg  |  | 
        |  |